Evolocumab vs. Ezetimibe in Statin-Intolerant Hyperlipidemic Japanese Patients: Phase 3 GAUSS-4 Trial

Aim: In patients with hyperlipidemia, intolerance to statins presents a challenge in reducing the risk of events associated with cardiovascular disease. This phase 3, randomized, double-blind trial in Japanese patients with statin intolerance aimed to evaluate the efficacy and safety of evolocumab v...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Atheroscler Thromb
Autors principals: Koba, Shinji, Inoue, Ikuo, Cyrille, Marcoli, Lu, Chen, Inomata, Hyoe, Shimauchi, Junichiro, Kajinami, Kouji
Format: Artigo
Idioma:Inglês
Publicat: Japan Atherosclerosis Society 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7242224/
https://ncbi.nlm.nih.gov/pubmed/31748467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.50963
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars